manilatimes.net
Neutralwww.manilatimes.net ·
ena respiratory successfully completes first part of phase ii study of inna 051 nasal spray designed to protect against symptomatic viral respiratory infections
WB_1434_HEART_DISEASEWB_1427_NON_COMMUNICABLE_DISEASE_AND_INJURYTAX_ETHNICITY_AMERICANECON_ENTREPRENEURSHIP
Topic context
This topic has been covered 338943 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
